13F Holdings
中文EN

SMTI Sanara MedTech Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 714256 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.8%
TTM net income YoY92.0%
TTM EPS YoY91.9%
Revenue 3-yr CAGR21.4%
Net income 3-yr CAGR—

Margins

Gross margin93.0%
Operating margin5.6%
Net margin-2.7%
FCF margin6.5%
EBITDA margin7.8%

Returns

ROE-43.7%
ROA-4.2%
ROIC (approx.)13.3%
Asset turnover1.56x

Leverage & solvency

Liabilities / assets89.4%
Debt / equity6.10x
Current ratio2.24x
Interest coverage0.86x

Cash quality & payout

Operating cash flow / net income-2.46x
Accruals ratio-14.6%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$103.12M$86.67M$64.99M$45.84M$24.14M
Cost of revenue$7.52M$8.14M$7.85M$6.36M$2.31M
Gross profit$95.60M$78.53M$57.14M$39.48M$21.83M
R&D expense$5.07M$2.83M$4.13M$3.37M$558,704
SG&A expense$78.72M$71.67M$56.99M$45.98M$28.05M
Operating income$7.30M$1.26M-$4.22M-$12.52M-$7.38M
Interest expense$6.76M$3.13M$475,783$284,746$711
Pretax income-$393,124-$1.89M-$4.44M-$13.94M-$7.99M
Income tax—$48,380—-$5.84M—
Net income-$37.56M-$9.66M-$4.30M-$7.94M-$7.92M
EBITDA$11.25M$6.18M-$540,127-$10.15M-$6.78M
EPS (basic)-4.36-1.14-0.52-1.00-1.08
EPS (diluted)-4.36-1.14-0.52-1.00-1.08
Weighted avg. shares (diluted)8.62M8.48M8.28M7.91M7.34M
Balance sheet
Cash & equivalents$16.58M$15.88M$5.15M$8.96M$18.65M
Receivables$12.00M——$6.81M$2.86M
Inventory$3.95M$2.75M$4.72M$3.55M$2.05M
Current assets$33.54M$33.31M$19.01M$20.62M$24.61M
PP&E, net$456,962$432,317$1.26M$1.42M$1.63M
Goodwill$3.60M$3.60M$3.60M$3.60M—
Intangibles$18.64M$23.48M$44.93M$31.51M$4.73M
Total assets$72.94M$88.09M$73.87M$61.04M$36.40M
Current liabilities$18.63M$15.29M$13.77M$12.81M$6.02M
Short-term debt——$580,357——
Long-term debt$45.97M$30.69M$9.11M——
Total debt$45.97M$30.69M$9.69M——
Total liabilities$67.01M$49.18M$29.28M$19.32M$6.24M
Shareholders' equity$5.94M$39.40M$44.83M$41.83M$30.64M
Net debt$29.39M$14.81M$4.55M——
Shares outstanding8.95M8.75M8.54M8.30M7.68M
Cash flow statement
Operating cash flow$6.79M-$23,784-$3.25M-$5.55M-$4.81M
Capital expenditure$4.63M$205,848$265,246$147,015$171,867
Free cash flow$2.16M-$229,632-$3.51M-$5.70M-$4.99M
Investing cash flow-$14.97M-$6.61M-$10.21M-$3.51M-$5.28M
Financing cash flow$8.89M$17.37M$9.64M-$627,346$28.30M
Depreciation & amortization$3.95M$4.92M$3.68M$2.37M$596,975
Stock-based compensation$5.15M$4.44M$3.44M$2.70M$2.67M

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.